Sales decline 51.44% to Rs 69.37 crore
Net Loss of Astec Lifesciences reported to Rs 39.72 crore in the quarter ended June 2024 as against net loss of Rs 8.19 crore during the previous quarter ended June 2023. Sales declined 51.44% to Rs 69.37 crore in the quarter ended June 2024 as against Rs 142.85 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales69.37142.85 -51 OPM %-66.672.19 -PBDT-52.37-1.62 -3133 PBT-61.64-11.01 -460 NP-39.72-8.19 -385Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
